|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/12 | |
| C07D 491/107 | |||
| A61K 9/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2958895 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14754329.2 |
| Europos patento paraiškos padavimo data | 2014-02-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/017270 |
| Data | 2014-02-20 |
| (87) | Numeris | WO 2014/130612 |
| Data | 2014-08-28 |
| (30) | Numeris | Data | Šalis |
| 201361767087 P | 2013-02-20 | US | |
| 201361898741 P | 2013-11-01 | US |
| (72) |
ONG, Winston Zapanta, US
NOWAK, Pawel Wojciech, US
ASKEW, Ben C., US
KIM, Jinsoo, US
|
| (73) |
Kala Pharmaceuticals, Inc.,
490 Arsenal Way, Suite 120, Watertown, MA 02472,
US
|
| (54) | THERAPEUTIC COMPOUNDS AND USES THEREOF |
| THERAPEUTIC COMPOUNDS AND USES THEREOF |